Blase Polite to Response Evaluation Criteria in Solid Tumors
This is a "connection" page, showing publications Blase Polite has written about Response Evaluation Criteria in Solid Tumors.
Connection Strength
0.080
-
Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies. Surgery. 2021 01; 169(1):162-167.
Score: 0.045
-
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 04; 18(4):446-453.
Score: 0.036